Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Disruption of the CXCR4-CXCL12 and VLA4-VCAM-1 axes may sensitize leukemia cells to chemotherapy

Feb. 22, 2007

Avalon begins drug discovery program targeting MYC oncoprotein

Feb. 22, 2007

Noscapine shows efficacy in prostate cancer

Feb. 22, 2007

Novel anticancer compounds described in recent patents

Feb. 22, 2007

ZIO-101 well tolerated in phase I study in multiple myeloma

Feb. 21, 2007

SGX reviews oncology pipeline

Feb. 20, 2007

Vinorelbine-cisplatin confirmed superior in stage II-IIIA NSCLC / News in Context

Feb. 20, 2007

Ariad plans IND for AP-24534 for CML

Feb. 19, 2007

Ariad advances phase III plans for AP-23573

Feb. 19, 2007

Rh-Apo2L begins phase II trials in China

Feb. 19, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...